| Tirzepatide once weekly for the treatment of obesity AM Jastreboff, LJ Aronne, NN Ahmad, S Wharton, L Connery, B Alves, ... New England Journal of Medicine 387 (3), 205-216, 2022 | 1418 | 2022 |
| American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity WT Garvey, JI Mechanick, EM Brett, AJ Garber, DL Hurley, AM Jastreboff, ... Endocrine Practice 22, 1-203, 2016 | 995 | 2016 |
| Stress as a common risk factor for obesity and addiction R Sinha, AM Jastreboff Biological psychiatry 73 (9), 827-835, 2013 | 825 | 2013 |
| Obesity as a disease: the obesity society 2018 position statement AM Jastreboff, CM Kotz, S Kahan, AS Kelly, SB Heymsfield Obesity 27 (1), 7-9, 2019 | 441 | 2019 |
| Triple–hormone-receptor agonist retatrutide for obesity—a phase 2 trial AM Jastreboff, LM Kaplan, JP Frías, Q Wu, Y Du, S Gurbuz, T Coskun, ... New England Journal of Medicine 389 (6), 514-526, 2023 | 324 | 2023 |
| Neural correlates of stress-and food cue–induced food craving in obesity: association with insulin levels AM Jastreboff, R Sinha, C Lacadie, DM Small, RS Sherwin, MN Potenza Diabetes care 36 (2), 394-402, 2013 | 269 | 2013 |
| Stress, cortisol, and other appetite‐related hormones: Prospective prediction of 6‐month changes in food cravings and weight AM Chao, AM Jastreboff, MA White, CM Grilo, R Sinha Obesity 25 (4), 713-720, 2017 | 224 | 2017 |
| Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial WT Garvey, JP Frias, AM Jastreboff, CW le Roux, N Sattar, D Aizenberg, ... The Lancet 402 (10402), 613-626, 2023 | 190 | 2023 |
| Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 … J Rosenstock, J Frias, AM Jastreboff, Y Du, J Lou, S Gurbuz, MK Thomas, ... The Lancet 402 (10401), 529-544, 2023 | 142 | 2023 |
| Clinical considerations regarding the use of obesity pharmacotherapy in adolescents with obesity G Srivastava, CK Fox, AS Kelly, AM Jastreboff, AF Browne, NT Browne, ... Obesity 27 (2), 190-204, 2019 | 132 | 2019 |
| Year in diabetes 2012: the diabetes tsunami R Sherwin, AM Jastreboff The Journal of Clinical Endocrinology & Metabolism 97 (12), 4293-4301, 2012 | 128 | 2012 |
| Altered brain response to drinking glucose and fructose in obese adolescents AM Jastreboff, R Sinha, J Arora, C Giannini, J Kubat, S Malik, ... Diabetes 65 (7), 1929-1939, 2016 | 92 | 2016 |
| Disordered eating behaviors in emerging adults with type 1 diabetes: a common problem for both men and women EA Doyle, SM Quinn, JM Ambrosino, K Weyman, WV Tamborlane, ... Journal of Pediatric Health Care 31 (3), 327-333, 2017 | 80 | 2017 |
| Leptin is associated with exaggerated brain reward and emotion responses to food images in adolescent obesity AM Jastreboff, C Lacadie, D Seo, J Kubat, MA Van Name, C Giannini, ... Diabetes care 37 (11), 3061-3068, 2014 | 79 | 2014 |
| Treatment of adolescent obesity in 2020 MI Cardel, AM Jastreboff, AS Kelly Jama 322 (17), 1707-1708, 2019 | 70 | 2019 |
| Preventing childhood obesity through a mindfulness-based parent stress intervention: A randomized pilot study AM Jastreboff, TM Chaplin, S Finnie, M Savoye, M Stults-Kolehmainen, ... The Journal of Pediatrics 202, 136-142. e1, 2018 | 65 | 2018 |
| The diagnosis and management of cerebrovascular disease in diabetes MS Phipps, AM Jastreboff, K Furie, WN Kernan Current diabetes reports 12, 314-323, 2012 | 60 | 2012 |
| Elevated dopamine D2/3 receptor availability in obese individuals: a PET imaging study with [11C](+) PHNO EC Gaiser, JD Gallezot, PD Worhunsky, AM Jastreboff, B Pittman, ... Neuropsychopharmacology 41 (13), 3042-3050, 2016 | 53 | 2016 |
| New frontiers in obesity treatment: GLP-1 and nascent nutrient-stimulated hormone-based therapeutics AM Jastreboff, RF Kushner Annual review of medicine 74 (1), 125-139, 2023 | 49 | 2023 |
| COVID‐19 vaccines are effective in people with obesity: a position statement from the Obesity Society WS Butsch, A Hajduk, MI Cardel, WT Donahoo, TK Kyle, FC Stanford, ... Obesity 29 (10), 1575-1579, 2021 | 49 | 2021 |
Rajita SinhaProfessor of psychiatry, neuroscience and child study, Yale Uni láVerified email at yale.edu